Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19200
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBIGIRUMURAME, Theophile-
dc.contributor.authorPERUALILA, Nolen Joy-
dc.contributor.authorSHKEDY, Ziv-
dc.contributor.authorKASIM, Adetayo-
dc.date.accessioned2015-09-23T13:35:16Z-
dc.date.available2015-09-23T13:35:16Z-
dc.date.issued2015-
dc.identifier.citationKepler, Johannes (Ed.) Proceedings of the 30th International Workshop on Statistical Modelling, p. 39-42-
dc.identifier.urihttp://hdl.handle.net/1942/19200-
dc.description.abstractThe drug discovery and development processes are typically costly and time consuming. Hence, it is crucial to identify early failure of candidate compounds and thereby save time and investment in a later stage. We propose structural equation modeling (SEM) based approach for an integrated analysis which combines information from three data sources: (1) bioactivity variables, (2) variables representing the chemical structure of the compounds, and (3) gene expression data. The proposed model allows to estimate the effects of the gene expression on the biological activity variable and furthermore, it allows to decompose the effect of the chemical structure on the biological activity into direct and indirect (i.e. the effect via the gene expression) effects.-
dc.language.isoen-
dc.subject.otherstructural equation modeling; microarray data; bioassays-
dc.titleIntegrated analysis of multi-source data in drug discovery experiments using structural equation models-
dc.typeProceedings Paper-
local.bibliographicCitation.authorsKepler, Johannes-
local.bibliographicCitation.conferencedateJuly 6-10, 2015-
local.bibliographicCitation.conferencename30th International Workshop on Statistical Modelling-
local.bibliographicCitation.conferenceplaceLinz, Austria-
dc.identifier.epage42-
dc.identifier.spage39-
local.bibliographicCitation.jcatC2-
dc.relation.referencesAmaratunga, D. , Cabrera, J. and Shkedy, Z. (2014), Exploration and Analysis of DNA Microarray and Other High Dimensional Data. New York: John Wiley. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (57), 289--300. Bollen, K.A.] (1998). Structural equation models. New York, Wiley Series in Probability and Mathematical Statistics. Wiley. Li, R. , Tsaih S.W., Shockley, K., Stylianou, I.M., Wergedal, J., Paigen, B., Churchill, G.A. (2006). Structural model analysis of multiple quantitative traits. PLoS Genet, (2)(7):e114. Verbist, B., Klambauer, G., Vervoort, L., Talloen, W., QSTAR Consortium, Shkedy, Z., Thas, O., Bender, A., Hinrich, W., G\"ohlmann, H., Hochreiter, S.,Bigirumurame, T. (2015). Using Transcriptomics to Guide Lead Optimization in Drug Discovery Projects: Lessons Learned from the QSTAR Project. Drug Discovery Today, In Press.-
local.type.refereedNon-Refereed-
local.type.specifiedProceedings Paper-
local.relation.ispartofseriesnr2-
dc.identifier.urlhttp://ifas.jku.at/iwsm2015/proceedings/-
local.bibliographicCitation.btitleProceedings of the 30th International Workshop on Statistical Modelling-
item.fullcitationBIGIRUMURAME, Theophile; PERUALILA, Nolen Joy; SHKEDY, Ziv & KASIM, Adetayo (2015) Integrated analysis of multi-source data in drug discovery experiments using structural equation models. In: Kepler, Johannes (Ed.) Proceedings of the 30th International Workshop on Statistical Modelling, p. 39-42.-
item.contributorBIGIRUMURAME, Theophile-
item.contributorPERUALILA, Nolen Joy-
item.contributorSHKEDY, Ziv-
item.contributorKASIM, Adetayo-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Bigirumurame.pdfPeer-reviewed author version208.52 kBAdobe PDFView/Open
Show simple item record

Page view(s)

36
checked on Sep 7, 2022

Download(s)

8
checked on Sep 7, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.